#AUA14 - Early experience of radium-223 treatment for metastatic castrate resistant prostate cancer: A preliminary report - Session Highlights
ORLANDO, FL USA (UroToday.com) - Radium-223 has recently been introduced for the treatment of metastatic castrate resistant prostate cancer (mCRPC).